1.Hereditary predisposition to ovarian cancer accounts for small (5–10%) but significant group of patients.
2.Recognition of this fact allows women and their physicians to assess the role of genetic counseling and testing to determine their risk.
3.If a mutation is detected, the risk of developing ovarian cancer is marked and interventions are warranted—either for early detection (surveillance) or for risk reduction (chemoprevention and surgery).
4.In 2004 the U.S. Surgeon General designated Thanksgiving as National Family History Day. Web-based tools, such as “My Family Health Portrait” are available to help organize family health information ().
Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML
Research suggests some patients with CML can safely discontinue TKI therapy - NCCN guidelines published.
To learn more about heredity and ovarian cancer, go to Ask the Doctor: Questions and Answers About Ovarian Cancer.